276 related articles for article (PubMed ID: 26468944)
21. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
22. The GAP activity of type III effector YopE triggers killing of Yersinia in macrophages.
Wang X; Parashar K; Sitaram A; Bliska JB
PLoS Pathog; 2014 Aug; 10(8):e1004346. PubMed ID: 25165815
[TBL] [Abstract][Full Text] [Related]
23. Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach.
Sory MP; Boland A; Lambermont I; Cornelis GR
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11998-2002. PubMed ID: 8618831
[TBL] [Abstract][Full Text] [Related]
24. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
Monnazzi LG; Carlos IZ; de Medeiros BM
Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
[TBL] [Abstract][Full Text] [Related]
25. DNA adenine methylase overproduction in Yersinia pseudotuberculosis alters YopE expression and secretion and host immune responses to infection.
Julio SM; Heithoff DM; Sinsheimer RL; Low DA; Mahan MJ
Infect Immun; 2002 Feb; 70(2):1006-9. PubMed ID: 11796641
[TBL] [Abstract][Full Text] [Related]
26. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response.
Falgarone G; Blanchard HS; Virecoulon F; Simonet M; Breban M
J Immunol; 1999 Mar; 162(5):2875-83. PubMed ID: 10072536
[TBL] [Abstract][Full Text] [Related]
27. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
Logsdon LK; Mecsas J
Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
[TBL] [Abstract][Full Text] [Related]
28. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
Viboud GI; So SS; Ryndak MB; Bliska JB
Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
Tansini A; de Medeiros BM
Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
[TBL] [Abstract][Full Text] [Related]
30. Yersinia controls type III effector delivery into host cells by modulating Rho activity.
Mejía E; Bliska JB; Viboud GI
PLoS Pathog; 2008 Jan; 4(1):e3. PubMed ID: 18193942
[TBL] [Abstract][Full Text] [Related]
31. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
32. Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo.
Autenrieth SE; Linzer TR; Hiller C; Keller B; Warnke P; Köberle M; Bohn E; Biedermann T; Bühring HJ; Hämmerling GJ; Rammensee HG; Autenrieth IB
PLoS Pathog; 2010 Nov; 6(11):e1001212. PubMed ID: 21124820
[TBL] [Abstract][Full Text] [Related]
33. The membrane localization domain is required for intracellular localization and autoregulation of YopE in Yersinia pseudotuberculosis.
Isaksson EL; Aili M; Fahlgren A; Carlsson SE; Rosqvist R; Wolf-Watz H
Infect Immun; 2009 Nov; 77(11):4740-9. PubMed ID: 19687205
[TBL] [Abstract][Full Text] [Related]
34. Splenic CD8α⁺ dendritic cells undergo rapid programming by cytosolic bacteria and inflammation to induce protective CD8⁺ T-cell memory.
Campisi L; Soudja SM; Cazareth J; Bassand D; Lazzari A; Brau F; Narni-Mancinelli E; Glaichenhaus N; Geissmann F; Lauvau G
Eur J Immunol; 2011 Jun; 41(6):1594-605. PubMed ID: 21469106
[TBL] [Abstract][Full Text] [Related]
35. CD8α⁺ dendritic cells improve collagen-induced arthritis in CC chemokine receptor (CCR)-2 deficient mice.
Ibarra JM; Quinones MP; Estrada CA; Jimenez F; Martinez HG; Ahuja SS
Immunobiology; 2011 Sep; 216(9):971-8. PubMed ID: 21531476
[TBL] [Abstract][Full Text] [Related]
36. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.
Westermark L; Fahlgren A; Fällman M
Infect Immun; 2014 Mar; 82(3):1181-91. PubMed ID: 24379291
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
[TBL] [Abstract][Full Text] [Related]
38. Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease.
Rüssmann H
Int J Med Microbiol; 2004 Apr; 293(7-8):565-9. PubMed ID: 15149032
[TBL] [Abstract][Full Text] [Related]
39. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
Neuenhahn M; Busch DH
Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
[TBL] [Abstract][Full Text] [Related]
40. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
Auerbuch V; Golenbock DT; Isberg RR
PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
